Skip to main content

Table 2 Non-hematologic toxicity by toxicity grade (NCI-CTC)

From: Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)

Toxicity

1

2

3

4

 

No.

%

No.

%

No.

%

No.

%

Anorexia

8

15.4

5

9.6

1

1.9

1

1.9

Nausea

11

21.2

2

3.8

1

1.9

0

0

Vomiting

5

9.6

1

1.9

1

1.9

0

0

Abdominal pain

4

7.7

4

7.7

1

1.9

0

0

Hot flushes

6

11.5

3

5.8

0

0

0

0

Sweating

7

13.5

4

7.7

0

0

0

0

Fatigue

9

17.3

9

17.3

2

3.8

0

0

Dizziness

5

9.6

1

1.9

1

1.9

0

0

Headache

4

7.7

2

3.8

0

0

0

0

Weight gain

4

7.7

1

1.9

0

0

0

0

Insomnia

5

9.6

4

7.7

0

0

0

0

Edema

3

5.8

1

1.9

0

0

0

0

Venous thrombosis

0

0

0

0

3

5.8

0

0